Table 2 Frequency of incidence/progression of MRI features in statin non-users and statin users
Overall | Statin non-users (n = 112.6) | Statin users (n = 9.4) | Chi square p value | |
|---|---|---|---|---|
Cartilage damage incidence/progression | 73.8 (60.5%) | 68.6 (60.9%) | 5.2 (55.3%) | 0.734 |
Osteophyte incidence/progression | 81.2 (66.6%) | 73.2 (65.0%) | 8.0 (85.2%) | 0.209 |
BML incidence/progression | 62.8 (51.5%) | 57.7 (51.2%) | 5.1 (54.8%) | 0.830 |
Effusion incidence/progression | 55.4 (45.4%) | 50.0 (44.4%) | 5.4 (57.3%) | 0.447 |